A detailed history of Frontier Capital Management CO LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 591,210 shares of EXAS stock, worth $34 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
591,210
Previous 705,468 16.2%
Holding current value
$34 Million
Previous $29.8 Million 35.06%
% of portfolio
0.4%
Previous 0.31%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $4.85 Million - $8.09 Million
-114,258 Reduced 16.2%
591,210 $40.3 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $2.04 Million - $3.67 Million
49,412 Added 7.53%
705,468 $29.8 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $4.15 Million - $5.45 Million
73,835 Added 12.68%
656,056 $45.3 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $6.68 Million - $8.57 Million
113,154 Added 24.12%
582,221 $43.1 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $4.03 Million - $6.05 Million
-61,067 Reduced 11.52%
469,067 $32 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $13.7 Million - $20.7 Million
-217,832 Reduced 29.12%
530,134 $49.8 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $5.39 Million - $8.08 Million
-114,129 Reduced 13.24%
747,966 $50.7 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $8.85 Million - $15.5 Million
291,616 Added 51.12%
862,095 $42.7 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.33 Million - $2.06 Million
41,719 Added 7.89%
570,479 $18.5 Million
Q2 2022

Jul 20, 2022

SELL
$35.61 - $76.23 $42,625 - $91,247
-1,197 Reduced 0.23%
528,760 $20.8 Million
Q1 2022

Apr 14, 2022

SELL
$57.56 - $82.54 $3.89 Million - $5.57 Million
-67,508 Reduced 11.3%
529,957 $37.1 Million
Q4 2021

Jan 19, 2022

SELL
$72.5 - $100.68 $2.15 Million - $2.98 Million
-29,595 Reduced 4.72%
597,465 $46.5 Million
Q3 2021

Oct 19, 2021

SELL
$90.24 - $124.05 $11.3 Million - $15.5 Million
-125,260 Reduced 16.65%
627,060 $59.9 Million
Q2 2021

Aug 09, 2021

SELL
$93.66 - $139.27 $394,870 - $587,162
-4,216 Reduced 0.56%
752,320 $93.5 Million
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $46.3 Million - $61.6 Million
-397,097 Reduced 34.42%
756,536 $99.7 Million
Q4 2020

Jan 19, 2021

SELL
$99.61 - $142.12 $27 Million - $38.5 Million
-271,000 Reduced 19.02%
1,153,633 $153 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $16.3 Million - $22.7 Million
-222,919 Reduced 13.53%
1,424,633 $145 Million
Q2 2020

Jul 17, 2020

BUY
$55.75 - $92.75 $23.5 Million - $39.1 Million
421,764 Added 34.41%
1,647,552 $143 Million
Q1 2020

Apr 16, 2020

BUY
$37.9 - $104.44 $7.31 Million - $20.1 Million
192,865 Added 18.67%
1,225,788 $71.1 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $14.2 Million - $18.3 Million
183,103 Added 21.55%
1,032,923 $95.5 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $1.68 Million - $2.28 Million
-18,636 Reduced 2.15%
849,820 $76.8 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $10.7 Million - $14.1 Million
-119,182 Reduced 12.07%
868,456 $103 Million
Q1 2019

May 07, 2019

SELL
$61.98 - $96.5 $15.3 Million - $23.9 Million
-247,208 Reduced 20.02%
987,638 $85.5 Million
Q4 2018

Jan 25, 2019

SELL
$56.04 - $82.66 $19.7 Million - $29 Million
-351,005 Reduced 22.13%
1,234,846 $77.9 Million
Q3 2018

Oct 30, 2018

BUY
$48.29 - $80.6 $21 Million - $35 Million
434,184 Added 37.7%
1,585,851 $125 Million
Q2 2018

Aug 03, 2018

BUY
$37.84 - $69.96 $1.15 Million - $2.13 Million
30,376 Added 2.71%
1,151,667 $68.9 Million
Q1 2018

Apr 30, 2018

BUY
$39.82 - $57.53 $9.13 Million - $13.2 Million
229,212 Added 25.69%
1,121,291 $45.2 Million
Q4 2017

Jan 18, 2018

SELL
$46.49 - $60.51 $1.15 Million - $1.49 Million
-24,634 Reduced 2.69%
892,079 $46.9 Million
Q3 2017

Oct 31, 2017

BUY
$37.05 - $47.12 $34 Million - $43.2 Million
916,713
916,713 $43.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.